Assignee

Isis Pharmaceuticals, Inc.

Patents = 1,035

Trademarks = 4

Forward Citations = 46,245

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

436 inventors (with patents filed for the assignee):

Isis Pharmaceuticals, Inc. is a biopharmaceutical company that focuses on discovering and developing RNA-targeted drugs for the treatment of various diseases. With a deep understanding of RNA biology and antisense technology, Isis Pharmaceuticals has successfully developed innovative therapies to address unmet medical needs. Their research and development efforts are aimed at transforming the way diseases are treated, particularly in areas such as cardiovascular, metabolic, neurodegenerative, and severe and rare diseases.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com